Financials PeptiDream Inc.

Equities

4587

JP3836750004

Biotechnology & Medical Research

Market Closed - Japan Exchange 02:00:00 2024-05-31 am EDT 5-day change 1st Jan Change
1,969 JPY +0.03% Intraday chart for PeptiDream Inc. +1.68% +32.46%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 269,659 192,662 255,198 - -
Enterprise Value (EV) 1 274,907 195,369 248,809 234,195 225,752
P/E ratio 35.7 x 63.5 x 16.2 x 30.6 x 24.1 x
Yield - - - 0.15% 0.3%
Capitalization / Revenue 10 x 6.71 x 5.9 x 6.74 x 5.98 x
EV / Revenue 10.2 x 6.8 x 5.75 x 6.18 x 5.29 x
EV / EBITDA 25.1 x 21.2 x 9.31 x 17.9 x 14.6 x
EV / FCF -72.3 x 17.4 x 11.9 x 22.3 x 17.8 x
FCF Yield -1.38% 5.74% 8.37% 4.49% 5.62%
Price to Book 8.42 x 4.78 x 5.09 x 4.33 x 3.64 x
Nbr of stocks (in thousands) 129,831 129,608 129,608 - -
Reference price 2 2,077 1,486 1,969 1,969 1,969
Announcement Date 2/14/23 2/14/24 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 26,852 28,712 43,249 37,877 42,666
EBITDA 1 10,954 9,206 26,732 13,117 15,414
EBIT 1 8,980 6,773 17,287 12,168 15,188
Operating Margin 33.44% 23.59% 39.97% 32.13% 35.6%
Earnings before Tax (EBT) 1 6,653 4,353 18,000 11,439 14,863
Net income 1 7,554 3,036 14,804 8,347 10,565
Net margin 28.13% 10.57% 34.23% 22.04% 24.76%
EPS 2 58.19 23.41 121.4 64.36 81.55
Free Cash Flow 1 -3,804 11,208 20,828 10,524 12,684
FCF margin -14.16% 39.04% 48.16% 27.78% 29.73%
FCF Conversion (EBITDA) - 121.74% 77.92% 80.23% 82.29%
FCF Conversion (Net income) - 369.19% 140.7% 126.08% 120.06%
Dividend per Share 2 - - - 3.000 6.000
Announcement Date 2/14/23 2/14/24 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 419 4,605 5,024 6,184 15,644 - 4,963 4,463 9,426 13,118 6,168 19,286 4,225 5,610 10,640 12,940 - -
EBITDA - - - - - - - - - - - - - - - - - -
EBIT 1 -1,166 -393 -1,559 1,133 9,407 - -266 -719.5 -986 7,739 20.2 7,759 -1,098 940 4,695 5,205 - -
Operating Margin -278.28% -8.54% -31.03% 18.32% 60.13% - -5.36% -16.12% -10.46% 59% 0.33% 40.23% -25.99% 16.76% 44.13% 40.22% - -
Earnings before Tax (EBT) -1,123 - -1,484 1,116 7,022 - -399 - -1,110 5,773 -308.5 5,464 -1,104 - - - - -
Net income -829 - -1,056 870 7,741 - -248 - -729 4,270 -505.6 3,765 -842 - 2,650 4,460 - -
Net margin -197.85% - -21.02% 14.07% 49.48% - -5% - -7.73% 32.55% -8.2% 19.52% -19.93% - 24.91% 34.47% - -
EPS 2 -6.390 - -8.130 6.690 59.63 66.32 -1.920 -3.700 -5.620 32.92 -3.890 29.03 -6.500 82.92 20.86 9.895 - -
Dividend per Share 2 - - - - - - - - - - - - - - - - - -
Announcement Date 5/12/22 8/9/22 8/9/22 11/10/22 2/14/23 2/14/23 5/11/23 8/9/23 8/9/23 11/9/23 2/14/24 2/14/24 5/14/24 - - - - -
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 5,248 2,707 - - -
Net Cash position 1 - - 6,388 21,002 29,446
Leverage (Debt/EBITDA) 0.4791 x 0.294 x - - -
Free Cash Flow 1 -3,804 11,208 20,828 10,524 12,684
ROE (net income / shareholders' equity) 26.3% 8.4% 28.4% 15.5% 17.2%
ROA (Net income/ Total Assets) 16.6% 6.53% 18.1% 5.5% 9.7%
Assets 1 45,450 46,493 81,787 151,756 108,915
Book Value Per Share 2 247.0 311.0 387.0 455.0 540.0
Cash Flow per Share 2 73.40 42.20 149.0 91.50 128.0
Capex 1 3,721 1,213 2,421 2,621 2,321
Capex / Sales 13.86% 4.22% 5.6% 6.92% 5.44%
Announcement Date 2/14/23 2/14/24 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,969 JPY
Average target price
2,850 JPY
Spread / Average Target
+44.74%
Consensus
  1. Stock Market
  2. Equities
  3. 4587 Stock
  4. Financials PeptiDream Inc.